Direct and Indirect Remuneration (DIR)

Pharmacy Direct and Indirect Remuneration (DIR) Value-based Pharmacy Reimbursement Reduces Drug Costs for Medicare Beneficiaries, Lowers Spending. Pharmacy direct and indirect remuneration, or Pharmacy DIR, is a form of value-based contracting in Medicare Part D.  Pharmacy DIR increases the quality

Read More »

Alan Lotvin

Executive Vice President, CVS Health President, CVS Caremark Alan Lotvin, M.D., is executive vice president of CVS Health, and president of CVS Caremark, the company’s pharmacy benefits management (PBM) business. In this role, Dr. Lotvin oversees all aspects of the

Read More »

Privacy Policy & Terms of Use

Disclaimer PCMA and sPCMA do not provide medical advice, diagnosis, treatment, or prescriptions. Any health information services, suggestions, or other content on pcmanet.org or spcma.org are for informational purposes only. Users assume full responsibility for the use of information obtained
Read More »

PCMA Annual Meeting 2020

Unprecedented times call for an unconventional PCMA Annual Meeting 2020. This best in class virtual event will take place on our originally scheduled dates of September 14 and 15, only instead of assembling in Scottsdale, the meeting has been reimagined
Read More »

COVID-19: Frequently Asked Questions

COVID-19: Frequently Asked Questions PBMs have substantial experience helping patients get the drugs and vaccines they need, including in times of crisis. PBMs are taking action to help educate the patients we serve about the safety and efficacy of authorized

Read More »

PBM Policy Forum 2021

With the public debate about prescription drug prices playing out in the press, in Congress, and among regulators, policymakers are focusing on the role of pharmacy benefit managers (PBMs) in addressing drug costs. Operating under contract with health plan sponsors
Read More »

Home Page

Unlocking an Affordable Future Unlocking an Affordable Future NEWSROOM PCMA Statement on Senate Judiciary Committee Hearing on Competition in The Prescription Drug Market NEWSROOM PCMA Statement on Senate Judiciary Committee Hearing on Competition in The Prescription Drug Market Stop The

Read More »